Oral Administration of Electron-Beam Inactivated Rhodococcus equi Failed to Protect Foals against Intrabronchial Infection with Live, Virulent R. equi.
Authors: Rocha Joana N, Cohen Noah D, Bordin Angela I, Brake Courtney N, Giguère Steeve, Coleman Michelle C, Alaniz Robert C, Lawhon Sara D, Mwangi Waithaka, Pillai Suresh D
Journal: PloS one
Summary
# Editorial Summary Rhodococcus equi pneumonia remains a significant disease in foals, and whilst oral vaccination with live organisms has shown promise in experimental settings, no licensed vaccine currently exists for field use. Researchers tested whether electron-beam inactivated R. equi—structurally intact but non-viable bacteria administered orally at 2, 7, and 14 days of age—could induce protective immunity against subsequent live virulent challenge at 21 days. Despite the inactivated vaccine being immunogenic, it failed to prevent pneumonia development: 7 of 8 vaccinated foals (88%) developed disease compared to 3 of 4 controls (75%), representing no meaningful protective benefit. These findings suggest that the oral gavage route and/or the dosing schedule used were insufficient to generate protective immunity, indicating that future vaccine development should explore alternative administration routes (intranasal or systemic), different inactivation methods, or enhanced immunogenic formulations to achieve the protection demonstrated by live organism exposure.
Read the full abstract on PubMed
Practical Takeaways
- •Oral vaccination with eBeam-inactivated R. equi at the tested doses and intervals does not provide reliable protection against R. equi pneumonia in foals—alternative strategies are needed.
- •The failure of this approach, despite theoretical immunogenicity, highlights the challenge of developing effective R. equi vaccines and the need for further research before clinical adoption.
- •Current disease management in R. equi-endemic operations should continue to rely on early detection and antibiotic treatment rather than vaccination with this formulation.
Key Findings
- •Oral eBeam-inactivated R. equi vaccination did not protect foals from pneumonia, with 88% of vaccinated foals (7/8) developing disease versus 75% of controls (3/4).
- •The vaccination regimen administered at days 2, 7, and 14 failed to generate protective immunity despite prior evidence that eBeam-inactivated bacteria are structurally intact and immunogenic.
- •Alternative dosing schedules and routes of administration warrant investigation as the current protocol was ineffective.